Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
Status:
Not yet recruiting
Trial end date:
2022-09-15
Target enrollment:
Participant gender:
Summary
Proportional dose of sublingual fentanyl tablet (Narco®) based on daily opioid requirement
versus intravenous PCA for breakthrough cancer pain: A prospective, randomized, open-label,
noninferiority trial.